Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Revenues			$ 16,146
Costs and operating expenses:
Cost of revenues			475
Research and development	$ 17,741	$ 14,687	44,723	$ 37,979
General and administrative	6,013	10,667	20,339	26,450
Total costs and operating expenses	23,754	25,354	65,537	64,429
Loss from operations	(23,754)	(25,354)	(49,391)	(64,429)
Other income, net:
Interest and investment income	1,846	1,707	5,419	5,036
Sublease income	705	598	2,212	1,200
Total other income, net	2,551	2,305	7,631	6,236
Net loss	$ (21,203)	$ (23,049)	$ (41,760)	$ (58,193)
Net loss per common share - basic	$ (0.35)	$ (0.56)	$ (0.73)	$ (1.52)
Net loss per common share - diluted	$ (0.35)	$ (0.56)	$ (0.73)	$ (1.52)
Weighted average shares of common stock outstanding - basic	60,715,041	41,331,806	57,511,997	38,379,401
Weighted average shares of common stock outstanding - diluted	60,715,041	41,331,806	57,511,997	38,379,401
Other comprehensive income (loss):
Net unrealized gain (loss) on marketable debt securities	$ 453	$ (20)	$ 288	$ (105)
Other comprehensive income (loss)	453	(20)	288	(105)
Comprehensive loss	$ (20,750)	$ (23,069)	(41,472)	$ (58,298)
Royalty Revenues
Revenues			8,146
Sale of Royalty Rights
Revenues			$ 8,000